Status: Recruiting

Suprachoroidal Administration in Subjects With Metastases to the Choroid

The primary objective is to assess the safety and tolerability of bel-sar treatment in subjects with metastases to the choroid from any primary solid tumor.

Participants needed: 24

Trial details

Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Aura BiosciencesUpdated: Mar 13, 2026Locations: 10

Eligibility criteria

Have a clinical diagnosis of Metastases to the Choroid, from a histopathological... [+1]

Active ocular infection or disease. [+2]

Status: Recruiting

Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects

To assess subject-centric real-world evidence of QoL outcomes in subjects enrolled in the global Phase 3 AU-011-301 clinical trial.

Participants needed: 15

Trial details

Biological sex: AllType: ObservationalSponsor: Aura BiosciencesUpdated: Feb 19, 2026Locations: 1

Eligibility criteria

Have enrolled in the Aura-sponsored clinical trial AU-011-301. [+1]

None

Clinical trials

Suprachoroidal Administration in Subjects With Metastases to the Choroid

Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects